Pharma Industry News

Biotronik Neuro snaps up spinal cord stimulation portfolio from Soin Neuroscience for next-gen pain project

Biotronik Neuro has acquired a portfolio of spinal cord stimulation patents from the Ohio-based medical device company Soin Neuroscience as the pair look to create “a next-generation spinal cord stimulation program.”

Source: FierceBiotech

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

Leave a Comment

[mwai_chat window="true" fullscreen="true"]